Bellevue Healthcare (LON:BBH) Stock Price Up 0.2% - Time to Buy?

Key Points

• Bellevue Healthcare's stock rose 0.2% during Tuesday's mid-day trading, with a last traded price of GBX 113.81 ($1.51).
• The company has a market cap of £280.49 million and a PE ratio of -17.31, indicating potential challenges in profitability.
• Bellevue Healthcare Trust plc targets a total dividend of 3.5 pence per share for the first financial period, primarily funded from capital.

Bellevue Healthcare (LON:BBH - ) rose 0.2% during mid-day trading on Tuesday . The stock traded as high as GBX 115 ($1.53) and last traded at GBX 113.81 ($1.51). Approximately 2,334,997 shares were traded during mid-day trading, an increase of 6% from the average daily volume of 2,195,712 shares. The stock had previously closed at GBX 113.60 ($1.51).

Bellevue Healthcare Price Performance

The company's fifty day moving average price is GBX 118.56 and its 200 day moving average price is GBX 125.03. The company has a market cap of £280.49 million and a PE ratio of -17.31.

Bellevue Healthcare Company Profile

Bellevue Healthcare Trust plc is a high conviction, long-only investment trust invested in listed or quoted global healthcare equities. It is unconstrained and able to invest regardless of market cap, sub sector or region, and the portfolio is concentrated with a maximum of 35 holdings. The target total dividend in the first financial period is 3.5 pence per ordinary share (to be paid mostly out of capital) and in subsequent financial years will be set at 3.5 per cent.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.